CD4 and neoplasm: Both vaccines with short (Qβ-NeoAgS) and long (Qβ-NeoAgL) peptides significantly hindered tumor growth compared with the control, but Qβ-NeoAgL showed an improved antitumor efficacy accompanied by increased CD8 and CD4 T cells and lower MDSC tumor infiltration.